Story thread · 16 reports / 10 sources
Novo Nordisk stock sinks 9% as heart drug fails trial
finance.yahoo.com · 11d
How the coverage leans
Across 10 sources · syndicated copies counted once
First report: Pfizer Inc. (PFE) vs. Eli Lilly and Company (LLY): The Growth vs. Value Play in Pharma — finance.yahoo.com, 12d
The coverage
- Novo drug trial fail deals setback to bid to expand beyond obesity
reuters.com · 11d
- Novo setback casts doubt on a new way to treat heart disease
biopharmadive.com · 11d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.